Vident Advisory’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.46M Sell
19,896
-44,698
-69% -$3.28M 0.02% 611
2025
Q1
$7.38M Sell
64,594
-45,184
-41% -$5.16M 0.11% 177
2024
Q4
$5.53M Sell
109,778
-6,114
-5% -$308K 0.1% 194
2024
Q3
$5.36M Sell
115,892
-70,128
-38% -$3.25M 0.14% 146
2024
Q2
$6.04M Buy
186,020
+3,601
+2% +$117K 0.17% 120
2024
Q1
$4.6M Buy
182,419
+94,266
+107% +$2.37M 0.1% 221
2023
Q4
$2.86M Sell
88,153
-40
-0% -$1.3K 0.07% 296
2023
Q3
$2.4M Buy
+88,193
New +$2.4M 0.07% 279